Recruiting

Observational Study

Sponsor:

Vanderbilt University Medical Center

Code:

NCT07529691

Conditions

Fibromuscular Dysplasia of Arteries

Fibromuscular Dysplasia

Spontaneous Coronary Artery Dissection

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Study Details

Brief summary:

Fibromuscular dysplasia (FMD) is a disease of the arteries that is not due to plaque build-up or inflammation. While some patients with FMD are health, some may experience heart attacks, strokes, aneurysms or blood vessel dissection/tearing which can be life-threatening. It predominantly impacts women and younger patients. As a result of this diagnosis, many patients are counseled to restrict or avoid certain physical activities out of concern for provoking or worsening vascular complications. There are no guidelines or consensus recommendations regarding appropriate physical activity for patients with FMD. The lack of consensus may lead to confusion for patients and may negatively impact their quality of life. This study will conduct a large, national survey of patients with FMD to assess the type of physical activity restrictions and impact on quality of life and emotional well-being.

Conditions

Fibromuscular Dysplasia of Arteries

Fibromuscular Dysplasia

Spontaneous Coronary Artery Dissection

Study ID

NCT07529691

Start date

Apr 14, 2026

Status verified date

Apr, 2026

Completion date

Jun 30, 2027

Anticipated

Primary completion date

Apr 30, 2027

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Inclusion criteria:

  • Participants with a diagnosis of fibromuscular dysplasia
  • Age range = 18-100 years

Exclusion Criteria:

  • Subjects who have an inability to complete the electronic consent form or electronic survey for any reason
  • Subjects who are non-English speaking who cannot read the electronic consent form or electronic survey

Study Design

Enrollment

2000 participants

Anticipated

Interventions and Outcome Measures

Arms

Patients with fibromuscular dysplasia

Patients who identify as having a confirmed diagnosis of fibromuscular dysplasia, or patients at Vanderbilt University Medical Center who have a confirmed diagnosis of fibromuscular dysplasia as determined by their provider.

Primary outcome measure

  • Clinician-Recommended Physical Activity Restrictions [ Time Frame: Baseline ]

Central Contacts and Locations

Central contacts

Locations

Vanderbilt University Medical Center

Recruiting

Nashville, Tennessee, United States, 37232

Contacts

Principal Investigator:

Amanda M Morrison, MD

More Information

Sponsor

Vanderbilt University Medical Center

Last update posted

Apr 20, 2026

Last verified

Apr, 2026

Keywords

  • FMD
  • Fibromuscular dysplasia
  • SCAD
  • Exercise
  • Quality of life

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Vanderbilt University Medical Center on 2026-04-20.